Scientists have developed a groundbreaking AI-designed gene-editing enzyme that significantly enhances the CRISPR toolkit. Published in Science on 16 July 2026, the study introduces a new class of synthetic enzymes called SynTnpBs, which outperform their natural counterparts in both efficiency and versatility. These enzymes, derived from the TnpB family, ancestors of widely used CRISPR-Cas12 systems, are engineered using an advanced AI model known as the ESM Inverse Folding (ESM-IF1) model. This breakthrough marks a major step forward in the quest to create entirely novel gene-editing tools with unique functionalities. The research team, led by Jennifer Doudna, a biochemist at the University of California, Berkeley, and a co-recipient of the 2020 Nobel Prize in Chemistry, sought to overcome a key limitation of existing CRISPR technologies. While traditional CRISPR systems rely on naturally occurring enzymes like Cas9 and Cas12, these enzymes are constrained by evolutionary history. Their structures and functions are optimized for survival in microbial environments, limiting their adaptability for applications in human cells or plants. By leveraging AI, the researchers aimed to generate enzymes with tailored properties that could perform tasks previously unattainable with natural proteins. The process began with the known three-dimensional structure of the TnpB enzyme. Using the ESM-IF1 model, the team inputted this structural data into the AI system, which then proposed numerous variations of the enzyme's amino acid sequence. The goal was to identify modifications that would preserve the enzyme's essential functions while introducing new capabilities. The AI model analyzed vast datasets of evolutionary relationships and protein interactions to determine which mutations would retain functionality without compromising performance. The resulting designs were then tested in bacterial cultures, followed by trials in human cell lines and Arabidopsis thaliana plant cells. Among the 1,980 candidate designs evaluated in bacterial screens, 466 demonstrated measurable activity. Notably, approximately 8% of these variants exhibited superior performance compared to the original TnpB enzyme. In human cells, two of the most effective variants achieved editing efficiencies of up to 50%, surpassing the 28% efficiency of the native enzyme. Some variants matched the original enzyme's effectiveness, while others showed remarkable improvements at specific DNA targets, achieving nearly four times greater editing accuracy. These findings underscore the potential of AI-driven protein design to revolutionize gene-editing capabilities. To ensure the new enzymes were sufficiently distinct from their natural predecessors, the researchers assessed the degree of divergence from the original TnpB. Unlike previous AI approaches that produced proteins with over 99% similarity to natural homologs, the ESM-IF1 model enabled the creation of enzymes with only 72% to 83% similarity to their closest natural counterparts. This reduced resemblance suggests that the AI-generated enzymes possess fundamentally different molecular interactions, potentially opening new avenues for therapeutic and agricultural applications. Despite these successes, the study acknowledges limitations. The current approach focuses on a single family of nucleases, meaning the methodology may not apply universally to all CRISPR systems. Nevertheless, the results highlight the promise of combining AI with structural biology to expand the designable protein space. As the field continues to evolve, further refinements could lead to even more efficient, smaller, and versatile gene-editing tools. The long-term vision, according to the researchers, is to develop fully synthetic enzymes capable of performing functions beyond what nature has already provided.
4 reports
Novara MediaIndependentCenterFactual 60Objective 657 days agoThe article discusses the growing phenomenon of AI boyfriends and girlfriends, exploring both their appeal and the controversies surrounding them. It questions whether such technologies enhance human relationships or merely represent an unrealistic fantasy. The piece highlights the ethical and labor implications of AI development, referencing James Muldoon's works which trace the journey of AI from exploitative labor conditions in East Africa to its role in personal relationships. The article does not take a clear stance but raises important questions about the societal impact of AI in intimate contexts.
Bias read (Center): The article presents a balanced exploration of AI companions without overtly favoring any ideological position. While it touches on ethical concerns and labor issues, it does not frame these topics in a clearly left or right-leaning manner. Instead, it focuses on presenting multiple perspectives and
Why these scores (Factual 60 · Objective 65): The article presents subjective views on AI relationships without clear factual grounding. It leans into opinion and speculation rather than presenting verifiable facts, and the tone is biased towards questioning the validity of AI companionship.
Phys.orgIndependentCenter5 hr. agoResearchers have developed a new AI-designed gene-editing enzyme called SynTnpB, which outperforms the natural TnpB enzyme in several applications. Using the ESM Inverse Folding (ESM-IF1) model, scientists redesigned TnpB by preserving essential amino acids for DNA/RNA recognition while altering other regions to enhance functionality. Testing in bacteria, human cells, and plant cells showed that SynTnpBs achieved significantly higher editing efficiencies compared to the natural enzyme, with some variants showing up to four times greater performance. The study highlights advancements in AI-driven protein design for creating novel gene-editing tools with improved capabilities.
Bias read (Center): The article presents scientific research without political implications. It focuses on technological advancement in gene-editing tools, describing findings objectively without advocacy or ideological framing.
Nature NewsIndependentCenteryesterdayOn 16 July 2026, researchers published findings in *Science* demonstrating that artificial intelligence can design synthetic CRISPR enzymes with enhanced functionality compared to natural variants. These AI-generated 'molecular scissors' could potentially revolutionize gene editing across various fields, including medicine and agriculture. The study, led by Jennifer Doudna, a Nobel laureate in Chemistry, explores the potential of AI to accelerate the discovery of new, functional nucleases. The research focuses on TnpB proteins, which are ancestral to widely used CRISPR components like Cas12. By leveraging AI, scientists aim to overcome limitations in traditional experimental methods, allowing for rapid exploration of protein designs that maintain biological activity.
Bias read (Center): The article presents scientific research without overt ideological framing. It discusses technological advancements in gene editing using AI, focusing on methodology, outcomes, and expert commentary. There is no indication of partisan bias or advocacy for specific political agendas. The tone remains
The EconomistIndependent🔒Center2 days agoThe article titled 'How Europe can compete on AI' by The Economist discusses the challenges and opportunities facing the European Union in developing artificial intelligence capabilities compared to global leaders like the United States and China. It highlights concerns over regulatory frameworks, investment in research and development, talent acquisition, and industrial competitiveness. The piece emphasizes the need for strategic investments, stronger collaboration between governments and private sector entities, and the importance of ethical standards in AI innovation. While acknowledging Europe’s strengths in data privacy and regulation, the article suggests that proactive measures are necessary to ensure the continent remains a significant player in the global AI landscape.
Bias read (Center): The article presents a balanced discussion of Europe's position in AI development, highlighting both its advantages and disadvantages without overtly favoring any particular political ideology. It focuses on strategic recommendations rather than taking a partisan stance, thus maintaining a center-bi
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
United Kingdom
.jpg&w=3840&q=75&output=webp&we)
